(Q37432717)

20 August 2017

1 reference

title

Skin cancer after transplantation (English)

1 reference

20 August 2017

1 reference

Bradley T Kovach

1

1 reference

20 August 2017

Thomas Stasko

series ordinal

2

1 reference

20 August 2017

publication date

2 April 2009

1 reference

20 August 2017

published in

Transplantation Reviews

1 reference

20 August 2017

volume

23

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

178-189

1 reference

Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Cancers in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Incidence of skin cancer after renal transplantation in The Netherlands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Guidelines for the management of squamous cell carcinoma in organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Skin cancer in heart transplant recipients: frequency and risk factor analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Cancer after kidney transplantation in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Risk factors for cancer in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Risk factors associated with the development of skin cancer after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Skin cancer in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

A population-based study of skin cancer incidence and prevalence in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Photochemical sensitization by azathioprine and its metabolites. Part 3. A direct EPR and spin-trapping study of light-induced free radicals from 6-mercaptopurine and its oxidation products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Effects of immunosuppressive therapy on the induction of skin tumors by ultraviolet irradiation in hairless mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Calcineurin inhibitors decrease DNA repair and apoptosis in human keratinocytes following ultraviolet B irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Human papillomaviruses in transplant-associated skin cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Skin cancer in Australian heart transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Treatment of nonmelanoma skin cancer in organ transplant recipients: review of responses to a survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

5% topical imiquimod tolerance in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Systemic strategies for chemoprevention of skin cancers in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Low-dose retinoid therapy for chemoprophylaxis of skin cancer in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Retinoids inhibit squamous cell carcinoma growth and intercellular communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Changes in Photo-Aged Human Skin Following Topical Application of All-Trans Retinoic Acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Retinoids strongly and selectively correlate with keratin 13 and not keratin 19 expression in cutaneous warts of renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Sirolimus for Kaposi's sarcoma in renal-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Management of cutaneous melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Increased incidence of melanoma in renal transplantation recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Malignant melanoma in renal-transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Melanomas in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Malignant melanoma in organ allograft recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Skin cancer as a contraindication to organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

High frequency and diversity of cutaneous appendageal tumors in organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

The role of immunosuppression in the pathogenesis of basal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Skin cancers after organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Regression of BCC following immunosuppression withdrawal in a renal transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Merkel's cell carcinoma in organ recipients: report of 41 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Merkel cell carcinoma in organ-transplant recipients: report of two cases with unusual histological features and literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Merkel cell carcinoma: report of 10 cases and review of the literature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Immunosuppression and Merkel cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Current management of patients with merkel cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Temporary regression of Merkel cell carcinoma metastases after cessation of cyclosporine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

Multiple atypical fibroxanthomas in a cardiac transplant recipient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2009.02.004

10.1016/J.TRRE.2009.02.004

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference